Journal of Pharmacological Sciences · 2007 · 19 citations · 12 references
MedicinePharmacologyPharmacotherapyPharmacodynamicsBlood-brain Barrier DysfunctionBlood-brain Barrier PharmacologyDiuretic TherapyEndothelial DysfunctionHypoxic-ischemic Brain InjuryNeuroprotectionBarrier Transport DysfunctionCerebral Endothelial Cell PharmacologyCerebral Ischemia PharmacotherapyCerebrovascular Endothelial InjuryIschemia-induced Barrier DisruptionMicrovascular IschemiaRodent Cerebral IschemiaThiazide Diuretic Therapy
The aim of the present study was to elucidate the effects of indapamide on ischemic damage to the blood-brain barrier (BBB) in vitro. The ischemia/reperfusion conditions employed here significantly decreased the viability of mouse brain capillary endothelial (MBEC4) cells, an effect ameliorated by indapamide. Ischemia increased the permeability of MBEC4 cells to two cellular transport markers, sodium fluorescein and Evan's blue-albumin. Indapamide reduced the ischemia-induced hyperpermeability of cells. These results suggest that indapamide may have a protective role against ischemia-induced injury and dysfunction of the BBB.
12
Functional involvement of P-glycoprotein in blood-brain barrier.
T Tatsuta, Mikihiko Naito, Tomoko Oh‐hara et al. · Journal of Biological Chemistry · 1992 · 353 citations · Full text
Medicine, Cell Biology, Pharmacology +17
Martha E. O’Donnell, Lien Tran, Tina I. Lam et al. · Journal of Cerebral Blood Flow & Metabolism · 2004 · 250 citations
Medicine, Neuroscience, Pharmacology +17